# Dermex Pharmaceutical, Inc. — Form D

Dermex Pharmaceutical, Inc. of ENGLEWOOD, CO, a company, filed a Form D exempt-offering notice with the SEC on 2012-12-13. The offering totals $300K, of which $25K was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2012-12-13
- Form: D
- Accession: 0001564270-12-000001
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $300K
- Amount sold: $25K
- Remaining: $275K
- Minimum investment: $10K
- Investors: 2
- Date of first sale: 2012-12-03
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-188294

## Issuer

- Name: Dermex Pharmaceutical, Inc.
- CIK: 0001564270
- Entity type: Corporation
- Jurisdiction: COLORADO
- Address: 14550 EAST EASTER AVEUNE, ENGLEWOOD, CO, 80112
- Phone: 303-358-0371

## Officers, directors & promoters (6)

| Name | Role | Location |
| --- | --- | --- |
| Dan Cleveland, Jr | Director | Englewood, CO |
| Carl Hanson | Director | Englewood, CO |
| Frank Potestio, II | Director | Englewood, CO |
| Carl Hanson | Executive Officer | Englewood, CO |
| Frank Potestio, II | Executive Officer | Englewood, CO |
| Michael Solhaug | Executive Officer | Englewood, CO |

## More

- [CIK 1564270 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1564270&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001564270-12-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.